跳轉至內容
Merck
全部照片(1)

Key Documents

WHAWB129241

QIAcard FTA DMPK Cards

FTA DMPK-A card, 4 sample areas per card, pack of 100 cards

同義詞:

QIAcard FTA DMPK-A (100), whatman dmpk, whatman fta

登入查看組織和合約定價


About This Item

分類程式碼代碼:
41105500
NACRES:
NB.22

材料

white

製造商/商標名

Qiagen WB129241

包裝

pack of 100 cards

尋找類似的產品? 前往 產品比較指南

一般說明

Drug Metabolism (DM) Pharmacokinetic (PK) studies provide crucial insight into the way drug candidates behave in the body. These studies are a critical step in drug development.

QIAcard FTA DMPK Cards for Drug Metabolism Pharmacokinetics enable microvolume sampling with only 10 to 20 µl per sample and are designed for use with blood samples. The cards can also be used with colorless samples such as plasma, cerebrospinal fluid and urine.

QIAcard FTA DMPK-A contains impregnated chemicals enabling protein denaturation to inactivate endogenous enzymes. Cell lysis releases endogenous cellular materials onto card. Stabilization of DNA allows resampling of blood spot for pharmacogenomics. Impregnated chemicals may interfere with mass spectrometry detection e.g. ion suppression.

特點和優勢

  • DBS microvolume sampling requires only 10—20 μl per sample.
  • Consistent data are obtained through more serial sampling from individual animals.
  • Less reliance on composite data.
  • The 3-step DBS procedure is more straightforward than the cumbersome centrifugation, isolation and clean-up of plasma.
  • Conveys greater analyte stability through on-substrate clean-up, especially for enzyme-sensitive compounds.
  • Room temperature stability saves on cost of dry ice shipments and allows remote sampling.

其他說明

Analysis is primarily with HPLC or UHPLC followed by MS/MS detection, direct desorption MS techniques such as DESI. Methanol or aqueous/organic mixtures have been shown to work well for small molecules and aqueous buffers are recommended for proteins. Select a good solvent for the analyte while maintaining compatibility with the HPLC conditions to be used. The choice of DMPK card depends on many factors such as the analyte chemical structure, extraction solvent and analysis workflow.

Field of Use : For internal research use only

法律資訊

FTA is a trademark of Qiagen Group
QIAcard is a trademark of Qiagen Group

從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

抱歉,我們目前沒有在線上提供本產品的COA

如果您需要協助,請聯絡 客戶支援

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Matthew Barfield et al.
Analytical chemistry, 83(1), 118-124 (2010-12-09)
A novel approach has been developed for the quantitative determination of circulating drug concentrations in clinical studies using dried plasma spots (DPS) on paper substrates, rather than conventional plasma samples. A quantitative bioanalytical high-pressure liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay
Neil Spooner et al.
Analytical chemistry, 81(4), 1557-1563 (2009-01-22)
A novel approach has been developed for the quantitative determination of circulating drug concentrations in clinical studies using dried blood spots (DBS) on paper, rather than conventional plasma samples. A quantitative bioanalytical HPLC-MS/MS assay requiring small blood volumes (15 microL)

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務